CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,017 | 2,406 | ||
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,528 | 0 | ||
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,713 | 0 | ||
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,406 | 0 | ||
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,238 | 1,250 | ||
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,250 | 0 | ||
| 2025-08-28 | Jacobson Allan Steven Director | Sale | −1,667 | $50.15 | $84K | 17,451 |
| 2025-08-15 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,813 | $25.69 | $72K | 106,714 |
| 2025-08-15 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −2,813 | $48.58 | $137K | 103,901 |
| 2025-08-15 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,813 | 24,899 | ||
| 2025-08-05 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,739 | $51.74 | $556K | 337,767 |
| 2025-08-01 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +75,000 | 348,506 | ||
| 2025-07-15 | Gravier Pierre CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,516 | $49.46 | $124K | 71,920 |
Page 25 of 25 · 493 trades